SCHEMBL4889016

SCHEMBL4889016

O=C(O)c1cn2c3c(cc(Br)cc3c1=O)COCC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.39
ADRA2B P18089 1/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 5/20 0.39
HPGD P15428 4/20 0.39
HSD17B10 Q99714 4/20 0.39
LMNA P02545 2/20 0.37
CYP1A2 P05177 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TOP1 P11387 1/20 0.35
TOP2A P11388 1/20 0.35
ALB P02768 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
POLB P06746 2/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4166569 0.84 KDM4E (0.44) KDM4EADRA2BMAPK1ALDH1A1HPGD
SCHEMBL4166123 0.83 LMNA (0.47) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL4175956 0.79 KDM4E (0.37) KDM4EADRA2BMAPK1ALDH1A1HPGD
SCHEMBL4169255 0.72 SIGMAR1 (0.38) ALDH1A1CYP2D6
SCHEMBL4186478 0.71 DDB1 (0.39) KDM4EADRA2BMAPK1ALDH1A1HPGD
SCHEMBL3982534 0.69 KDM4E (0.44) KDM4EADRA2BMAPK1ALDH1A1HPGD
SCHEMBL11258443 0.68 KDM4E (0.44) KDM4EADRA2BMAPK1ALDH1A1HPGD
SCHEMBL4131074 0.68 KDM4E (0.74) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL4131070 0.68 KDM4E (0.74) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL4154463 0.68 KDM4E (0.38) KDM4EADRA2BMAPK1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096829-A1 Macrolone Compounds GLAXO GROUP LIMITED (GB) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096829-A1 Macrolone Compounds MRPL21, MRPS18A, MRPL19 KDM4E 4136/4885ADRA2B 2848/4885MAPK1 2012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.